Centene Corp
CNC: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| SP | LOCK|tgt | LOCK|XN^y?> |
Centene: Withdrawn 2025 Guidance Adds Uncertainty to Near-Term Prospects
Centene withdrew its guidance primarily due to challenges in its individual plans, including elevated medical utilization that is also plaguing the Medicaid market. Management quantified the known EPS risks in 72% of its individual members at $2.75 of its withdrawn 2025 view of at least $7.25.
